-
-
Overview
-
PF-05231023 is novel and potent, long-acting FGF21-receptor agonist being developed as a potential treatment for T2DM. PF-05231023 is a FGF21 mimetic that decreases body weight and improves lipid profile in non-human primates and in type 2 diabetic subjects.
Please contact us at for specific academic pricing.
-
- Properties
-
Overview